筋弛緩薬市場- 薬剤タイプ、剤形、用途、投与経路、流通チャネル別、世界予測、2023-2032年

世界の筋弛緩薬市場は、2023年から2032年にかけてCAGR 6.4％で成長します。

高齢化により筋骨格系の疾患や症状の発生率が増加しており、筋弛緩薬ビジネスの原動力となっています。

さらに、ストレスレベルの上昇と座りっぱなしのライフスタイルが筋肉関連の問題の急増に寄与し、業界の成長をさらに後押ししています。疼痛管理におけるこれらの薬剤の有効性に対する認識の高まりと、筋骨格系疾患以外の治療用途の拡大は、事業の成長を促進します。

また、新規製剤のイントロダクションや、非中毒性の代替薬の追求も、市場拡大に拍車をかけると予想されます。2022年6月、Amneal Pharmaceuticals社はバクロフェンを含有する革新的な経口顆粒薬であるLYVISPAHを発表し、多発性硬化症や様々な脊髄障害などの症状に伴う痙縮の治療薬としてUSFDAから承認を取得しました。

市場は薬剤タイプ、剤形、用途、投与経路、流通チャネル、地域によって分類されます。

薬剤タイプ別に見ると、顔面筋弛緩薬セグメントは2032年までCAGR 5.7%を記録すると予想され、非侵襲的美容整形に対する需要の高まり、美的向上に対する嗜好の高まり、顔面若返り技術の進歩がその要因となっています。さらに、顔面筋弛緩治療を求める高齢化人口の増加がこのセグメントの成長を促進します。

液体剤形セグメントは、投与が容易、作用発現が早い、患者のコンプライアンスが向上するなどの要因によって、分析期間中にCAGR 6.1％を示すと思われます。液体製剤は、その利便性と迅速な治療効果のために好まれています。

外科用途セグメントは、2032年までのCAGRが5.7％になると予想されます。低侵襲手術を含む外科手術の増加が、手術用筋弛緩薬ビジネスの原動力となると思われます。外科医は、手術の正確性と患者の安全性を高めるために筋弛緩薬を利用しており、市場拡大を牽引しています。

地域別では、アジア太平洋の筋弛緩薬産業は、高齢化、筋骨格系障害の有病率の上昇、ヘルスケアインフラの増加、治療オプションに対する意識の高まりに牽引され、2023年から2032年にかけてCAGR 7.3%で成長すると予測されます。さらに、医薬品の技術革新と医療アクセスの拡大が、同地域の事業成長を増大させると思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 筋弛緩薬市場の洞察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • 慢性疾患と結びついた老人人口の増加
    • 筋骨格系疾患の有病率の増加
    • 医薬品開発の進展
  • 業界の潜在的リスク＆課題
    • 筋弛緩剤に伴う副作用
    • 厳しい規制基準
• 成長可能性分析
• COVID-19の影響分析
• 規制状況
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 筋弛緩薬の市場推定・予測：薬剤タイプ別、2018年～2032年

• 主要動向：薬剤タイプ別
• 骨格筋弛緩薬
• 神経筋遮断薬
• 顔面筋弛緩薬

第6章 筋弛緩薬の市場推定・予測：剤形別、2018年～2032年

• 主要動向：剤形別
• 錠剤
• カプセル剤
• 液剤
• ゲル、軟膏、スプレー

第7章 筋弛緩薬の市場推定・予測：用途別、2018年～2032年

• 主要動向：用途別
• 筋痙攣および疼痛緩和
• 筋骨格系障害
• 外科疾患
• その他の用途

第8章 筋弛緩薬の市場推定・予測：投与経路別、2018年～2032年

• 主要動向：投与経路別
• 経口
• 非経口
• 局所

第9章 筋弛緩薬の市場推定・予測：流通チャネル別、2018年～2032年

• 主要動向：流通チャネル別
• 病院薬局
• 専門・小売薬局
• オンライン薬局

第10章 筋弛緩薬の市場推定・予測：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第11章 企業プロファイル

• Amneal Pharmaceuticals LLC
• Ipsen Biopharmaceuticals, Inc.
• Merz Pharmaceuticals, LLC.
• Mylan（Viatris）
• Sanofi
• Pfizer Inc
• Novartis AG
• Teva Pharmaceuticals Industries Ltd, Inc.
• Vertical Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• SteriMax Inc
• Par Pharmaceutical
• Abbott Laboratories
• F. Hoffmann-La Roche AG

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug type (2022)
• TABLE 3 Market revenue, by dosage form (2022)
• TABLE 4 Market revenue, by application (2022)
• TABLE 5 Market revenue, by route of administration (2022)
• TABLE 6 Market revenue, by distribution channel (2022)
• TABLE 7 Market share, by region (2022)
• TABLE 8 Global muscle relaxant drugs market size, by region, 2018 - 2022 (USD Million)
• TABLE 9 Global muscle relaxant drugs market size, by region, 2023 - 2032 (USD Million)
• TABLE 10 Global muscle relaxant drugs market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 11 Global muscle relaxant drugs market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 12 Global muscle relaxant drugs market size, by dosage form, 2018 - 2022 (USD Million)
• TABLE 13 Global muscle relaxant drugs market size, by dosage form, 2023 - 2032 (USD Million)
• TABLE 14 Global muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 15 Global muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 16 Global muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 17 Global muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 18 Global muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 19 Global muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 20 Industry impact forces
• TABLE 21 Skeletal muscle relaxant drugs market size, 2018-2022 (USD Million)
• TABLE 22 Skeletal muscle relaxant drugs market size, 2023-2032 (USD Million)
• TABLE 23 Neuromuscular blocking agents market size, 2018-2022 (USD Million)
• TABLE 24 Neuromuscular blocking agents market size, 2023-2032 (USD Million)
• TABLE 25 Facial muscle relaxant drugs market size, 2018-2022 (USD Million)
• TABLE 26 Facial muscle relaxant drugs market size, 2023-2032 (USD Million)
• TABLE 27 Tablet market size, 2018-2022 (USD Million)
• TABLE 28 Tablet market size, 2023-2032 (USD Million)
• TABLE 29 Capsule market size, 2018-2022 (USD Million)
• TABLE 30 Capsule market size, 2023-2032 (USD Million)
• TABLE 31 Liquid market size, 2018-2022 (USD Million)
• TABLE 32 Liquid market size, 2023-2032 (USD Million)
• TABLE 33 Gel, ointments & sprays market size, 2018-2022 (USD Million)
• TABLE 34 Gel, ointments & sprays market size, 2023-2032 (USD Million)
• TABLE 35 Muscle spasm & pain relief market size, 2018-2022 (USD Million)
• TABLE 36 Muscle spasm & pain relief market size, 2023-2032 (USD Million)
• TABLE 37 Musculoskeletal disorders market size, 2018-2022 (USD Million)
• TABLE 38 Musculoskeletal disorders market size, 2023-2032 (USD Million)
• TABLE 39 Surgery market size, 2018-2022 (USD Million)
• TABLE 40 Surgery market size, 2023-2032 (USD Million)
• TABLE 41 Other applications market size, 2018-2022 (USD Million)
• TABLE 42 Other applications market size, 2023-2032 (USD Million)
• TABLE 43 Oral market size, 2018-2022 (USD Million)
• TABLE 44 Oral market size, 2023-2032 (USD Million)
• TABLE 45 Parenteral market size, 2018-2022 (USD Million)
• TABLE 46 Parenteral market size, 2023-2032 (USD Million)
• TABLE 47 Topical market size, 2018-2022 (USD Million)
• TABLE 48 Topical market size, 2023-2032 (USD Million)
• TABLE 49 Hospital pharmacy market size, 2018-2022 (USD Million)
• TABLE 50 Hospital pharmacy market size, 2023-2032 (USD Million)
• TABLE 51 Specialty & Retail pharmacy market size, 2018-2022 (USD Million)
• TABLE 52 Specialty & Retail pharmacy market size, 2023-2032 (USD Million)
• TABLE 53 Online pharmacy market size, 2018-2022 (USD Million)
• TABLE 54 Online pharmacy market size, 2023-2032 (USD Million)
• TABLE 55 North America muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 56 North America muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 57 North America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 58 North America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 59 North America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 60 North America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 61 North America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 62 North America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 63 North America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 64 North America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 65 North America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 66 North America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 67 U.S. muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 68 U.S. muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 69 U.S. muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 70 U.S. muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 71 U.S. muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 72 U.S. muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 73 U.S. muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 74 U.S. muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 75 U.S. muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 76 U.S. muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 77 Canada muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 78 Canada muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 79 Canada muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 80 Canada muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 81 Canada muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 82 Canada muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 83 Canada muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 84 Canada muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 85 Canada muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 86 Canada muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 87 Europe muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 88 Europe muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 89 Europe muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 90 Europe muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 91 Europe muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 92 Europe muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 93 Europe muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 94 Europe muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 95 Europe muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 96 Europe muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 97 Europe muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 98 Europe muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 99 Germany muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 100 Germany muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 101 Germany muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 102 Germany muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 103 Germany muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 104 Germany muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 105 Germany muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 106 Germany muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 107 Germany muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 108 Germany muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 109 UK muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 110 UK muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 111 UK muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 112 UK muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 113 UK muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 114 UK muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 115 UK muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 116 UK muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 117 UK muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 118 UK muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 119 France muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 120 France muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 121 France muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 122 France muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 123 France muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 124 France muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 125 France muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 126 France muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 127 France muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 128 France muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 129 Spain muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 130 Spain muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 131 Spain muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 132 Spain muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 133 Spain muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 134 Spain muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 135 Spain muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 136 Spain muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 137 Spain muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 138 Spain muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 139 Italy muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 140 Italy muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 141 Italy muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 142 Italy muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 143 Italy muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 144 Italy muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 145 Italy muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 146 Italy muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 147 Italy muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 148 Italy muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 149 Rest of Europe muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 150 Rest of Europe muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 151 Rest of Europe muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 152 Rest of Europe muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 153 Rest of Europe muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 154 Rest of Europe muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 155 Rest of Europe muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 156 Rest of Europe muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 157 Rest of Europe muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 158 Rest of Europe muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 159 Asia Pacific muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 160 Asia Pacific muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 161 Asia Pacific muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 162 Asia Pacific muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 163 Asia Pacific muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 164 Asia Pacific muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 165 Asia Pacific muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 166 Asia Pacific muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 167 Asia Pacific muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 168 Asia Pacific muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 169 Asia Pacific muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 170 Asia Pacific muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 171 China muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 172 China muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 173 China muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 174 China muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 175 China muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 176 China muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 177 China muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 178 China muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 179 China muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 180 China muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 181 Japan muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 182 Japan muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 183 Japan muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 184 Japan muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 185 Japan muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 186 Japan muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 187 Japan muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 188 Japan muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 189 Japan muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 190 Japan muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 191 India muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 192 India muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 193 India muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 194 India muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 195 India muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 196 India muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 197 India muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 198 India muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 199 India muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 200 India muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 201 Australia muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 202 Australia muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 203 Australia muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 204 Australia muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 205 Australia muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 206 Australia muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 207 Australia muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 208 Australia muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 209 Australia muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 210 Australia muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 211 Rest of Asia Pacific muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 212 Rest of Asia Pacific muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 213 Rest of Asia Pacific muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 214 Rest of Asia Pacific muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 215 Rest of Asia Pacific muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 216 Rest of Asia Pacific muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 217 Rest of Asia Pacific muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 218 Rest of Asia Pacific muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 219 Rest of Asia Pacific muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 220 Rest of Asia Pacific muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 221 Latin America muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 222 Latin America muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 223 Latin America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 224 Latin America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 225 Latin America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 226 Latin America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 227 Latin America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 228 Latin America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 229 Latin America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 230 Latin America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 231 Latin America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 232 Latin America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 233 Brazil muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 234 Brazil muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 235 Brazil muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 236 Brazil muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 237 Brazil muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 238 Brazil muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 239 Brazil muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 240 Brazil muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 241 Brazil muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 242 Brazil muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 243 Mexico muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 244 Mexico muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 245 Mexico muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 246 Mexico muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 247 Mexico muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 248 Mexico muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 249 Mexico muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 250 Mexico muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 251 Mexico muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 252 Mexico muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 253 Rest of Latin America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 254 Rest of Latin America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 255 Rest of Latin America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 256 Rest of Latin America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 257 Rest of Latin America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 258 Rest of Latin America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 259 Rest of Latin America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 260 Rest of Latin America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 261 Rest of Latin America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 262 Rest of Latin America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 263 Middle East & Africa muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 264 Middle East & Africa muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 265 Middle East & Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 266 Middle East & Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 267 Middle East & Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 268 Middle East & Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 269 Middle East & Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 270 Middle East & Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 271 Middle East & Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 272 Middle East & Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 273 Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 274 Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 275 South Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 276 South Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 277 South Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 278 South Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 279 South Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 280 South Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 281 South Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 282 South Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 283 South Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 284 South Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 285 Saudi Arabia muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 286 Saudi Arabia muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 287 Saudi Arabia muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 288 Saudi Arabia muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 289 Saudi Arabia muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 290 Saudi Arabia muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 291 Saudi Arabia muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 292 Saudi Arabia muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 293 Saudi Arabia muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 294 Saudi Arabia muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 295 Rest of Middle East & Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 296 Rest of Middle East & Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 297 Rest of Middle East & Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 298 Rest of Middle East & Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 299 Rest of Middle East & Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 300 Rest of Middle East & Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 301 Rest of Middle East & Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 302 Rest of Middle East & Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 303 Rest of Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 304 Rest of Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 Industry segmentation
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Muscle relaxant drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry ecosystem analysis
• FIG 8 Growth potential analysis, by drug type
• FIG 9 Growth potential analysis, by dosage form
• FIG 10 Growth potential analysis, by application
• FIG 11 Growth potential analysis, by route of administration
• FIG 12 Growth potential analysis, by distribution channel
• FIG 13 Porter's analysis
• FIG 14 PESTEL analysis
• FIG 15 Company matrix analysis, 202
• FIG 16 Competitive analysis of major market players, 2022
• FIG 17 Competitive positioning matrix
• FIG 18 Strategic dashboard

The global muscle relaxant drugs market will grow at a 6.4% CAGR from 2023 to 2032. An aging population is experiencing an increased incidence of musculoskeletal disorders and conditions, driving the business for muscle relaxant medications.

Additionally, rising stress levels and sedentary lifestyles contribute to a surge in muscle-related issues, further boosting the industry's growth. The growing awareness of the efficacy of these drugs in pain management and the expansion of therapeutic applications beyond just musculoskeletal disorders will drive business growth.

The introduction of novel formulations and the pursuit of non-addictive alternatives are also anticipated to fuel market expansion. In June 2022, Amneal Pharmaceuticals introduced LYVISPAH, an innovative oral granules medication containing baclofen, which has received approval from the USFDA for the treatment of spasticity associated with conditions such as multiple sclerosis and various spinal cord disorders.

The market is categorized based on drug type, dosage form, application, route of administration, distribution channel, and region.

Based on drug type, the facial muscle relaxant drug segment will record a 5.7% CAGR through 2032, driven by the rising demand for non-invasive cosmetic procedures, growing preference for aesthetic enhancements, and advancements in facial rejuvenation technologies. Moreover, rising aging population seeking facial muscle relaxation treatments will foster growth in the segment.

The liquid dosage form segment will exhibit a 6.1% CAGR during the analysis period, driven by factors such as ease of administration, faster onset of action, and improved patient compliance. Liquid formulations are preferred for their convenience and quicker therapeutic effects.

The surgery application segment will reflect a 5.7% CAGR through 2032. Increasing surgical procedures, including minimally invasive surgeries will drive the business of muscle relaxant drugs for surgery. Surgeons rely on muscle relaxants to enhance surgical precision and patient safety, driving market expansion.

Regionally, the Asia Pacific muscle relaxant drugs industry is anticipated to grow at a 7.3% CAGR during 2023-2032, driven by the aging population, rising prevalence of musculoskeletal disorders, increasing healthcare infrastructure, and a growing awareness of treatment options. Moreover, pharmaceutical innovation and expanding healthcare access will augment business growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Global muscle relaxant drugs market 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug type trends
  • 2.1.4 Dosage form trends
  • 2.1.5 Application trends
  • 2.1.6 Route of administration trends
  • 2.1.7 Distribution channel trends

Chapter 3 Muscle Relaxant Drugs Market Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing geriatric population coupled with chronic diseases
    • 3.2.1.2 Increasing prevalence of musculoskeletal disorders
    • 3.2.1.3 Growing advancement in drug development
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side-effects associated with muscle relaxants
    • 3.2.2.2 Strict regulatory norms
• 3.3 Growth potential analysis
  • 3.3.1 By drug type
  • 3.3.2 By dosage form
  • 3.3.3 By application
  • 3.3.4 By route of administration
  • 3.3.5 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Muscle Relaxant Drugs Market Estimates and Forecast, By Drug Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by drug type
• 5.2 Skeletal muscle relaxant drugs
• 5.3 Neuromuscular blocking agents
• 5.4 Facial muscle relaxant drugs

Chapter 6 Muscle Relaxant Drugs Market Estimates and Forecast, By Dosage Form, 2018 - 2032 (USD Million)

• 6.1 Key trends, by dosage form
• 6.2 Tablet
• 6.3 Capsule
• 6.4 Liquid
• 6.5 Gel, ointments & sprays

Chapter 7 Muscle Relaxant Drugs Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Muscle spasm & pain relief
• 7.3 Musculoskeletal disorders
• 7.4 Surgery
• 7.5 Other applications

Chapter 8 Muscle Relaxant Drugs Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

• 8.1 Key trends, by route of administration
• 8.2 Oral
• 8.3 Parenteral
• 8.4 Topical

Chapter 9 Muscle Relaxant Drugs Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

• 9.1 Key trends, by distribution channel
• 9.2 Hospital pharmacy
• 9.3 Specialty & Retail pharmacy
• 9.4 Online pharmacy

Chapter 10 Muscle Relaxant Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 Amneal Pharmaceuticals LLC
• 11.2 Ipsen Biopharmaceuticals, Inc.
• 11.3 Merz Pharmaceuticals, LLC.
• 11.4 Mylan (Viatris)
• 11.5 Sanofi
• 11.6 Pfizer Inc
• 11.7 Novartis AG
• 11.8 Teva Pharmaceuticals Industries Ltd, Inc.
• 11.9 Vertical Pharmaceuticals
• 11.10 Sun Pharmaceutical Industries Ltd.
• 11.11 SteriMax Inc
• 11.12 Par Pharmaceutical
• 11.13 Abbott Laboratories
• 11.14 F. Hoffmann-La Roche AG